Brinker Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$860K Buy
59,574
+7,839
+15% +$103K 0.03% 544
2020
Q1
$565K Buy
51,735
+3,310
+7% +$61K 0.02% 600
2019
Q4
$1.03M Sell
48,425
-1,975
-4% -$44.2K 0.03% 493
2019
Q3
$1.16M Buy
50,400
+3,980
+9% +$84.9K 0.04% 441
2019
Q2
$914K Buy
46,420
+4,885
+12% +$95.2K 0.03% 502
2019
Q1
$809K Buy
41,535
+9,855
+31% +$187K 0.03% 526
2018
Q4
$522K Sell
31,680
-10,663
-25% -$215K 0.02% 587
2018
Q3
$979K Buy
42,343
+339
+0.8% +$7.68K 0.04% 503
2018
Q2
$913K Buy
42,004
+2,614
+7% +$51.1K 0.04% 510
2018
Q1
$695K Buy
39,390
+3,833
+11% +$67.6K 0.03% 596
2017
Q4
$667K Buy
35,557
+9,799
+38% +$195K 0.03% 594
2017
Q3
$565K Buy
25,758
+11,306
+78% +$255K 0.02% 626
2017
Q2
$348K Sell
14,452
-4,697
-25% -$119K 0.02% 588
2017
Q1
$535K Buy
+19,149
New +$502K 0.03% 583

Other funds holding SBRA

Brinker Capital's SBRA Position: Q2 2020 in Review

Brinker Capital increased its Sabra Healthcare REIT (SBRA) stake by 15% in Q2 2020, buying an estimated $103K and bringing the position to 59,574 shares worth $860K. The position accounts for 0.03% of the portfolio, ranked #544.

Brinker Capital first reported a position in SBRA in Q1 2017 and has held it in 14 quarters since. The position peaked at $1.16M in Q3 2019. 317 funds tracked by Wall St. Rank hold SBRA as of Q2 2020.

  • Brinker Capital held 59,574 shares of Sabra Healthcare REIT worth $860K as of Q2 2020.
  • Brinker Capital bought 7,839 Sabra Healthcare REIT shares in Q2 2020, an estimated $103K.
  • Sabra Healthcare REIT made up 0.03% of Brinker Capital's portfolio in Q2 2020, its #544 holding.
  • Brinker Capital first reported a position in Sabra Healthcare REIT in Q1 2017 and has held it in 14 quarters since.
  • Brinker Capital's Sabra Healthcare REIT position peaked at $1.16M in Q3 2019.
  • 317 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.